Medidata Co-Founder Says Future Trends Explain Logic For Buying SHYFT Analytics
Executive Summary
Medidata president says buying SHYFT Analytics creates unified trial, commercialization data platform for life sciences sector, offering reduced risk, faster drug development, better outcomes.